Document Detail


Bromocriptine: Its place in type 2 diabetes Tx.
MedLine Citation:
PMID:  22049355     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
Patients intolerant of other diabetes medications or requiring minimal A1c reduction may benefit from bromocriptine.
Authors:
Karen R Sando; James Taylor
Related Documents :
17327445 - Paradoxical changes in muscle gene expression in insulin-resistant subjects after susta...
10905485 - Interaction between insulin sensitivity and muscle perfusion on glucose uptake in human...
14749265 - The biology of peroxisome proliferator-activated receptors: relationship with lipid met...
20854065 - Hypoadiponectinemia is closely associated with impaired nitric oxide synthase activity ...
8137525 - Prospective evaluation of insulin resistance and lipid metabolism in women receiving or...
8334825 - Prognosis of acute myocardial infarction in diabetic and non-diabetic patients.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  The Journal of family practice     Volume:  60     ISSN:  1533-7294     ISO Abbreviation:  J Fam Pract     Publication Date:  2011 Nov 
Date Detail:
Created Date:  2011-11-03     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7502590     Medline TA:  J Fam Pract     Country:  United States    
Other Details:
Languages:  eng     Pagination:  E1-5     Citation Subset:  AIM; IM    
Affiliation:
University of Florida, College of Pharmacy, Department of Pharmacotherapy and Translational Research, Gainesville, FL, USA. Email: ksando@cop.ufl.edu.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Clinical Inquiry: Which combination drug therapies are most effective for hypertension?
Next Document:  Preparation of highly specific anti-zearalenone antibodies by using the cationic protein conjugate a...